全文获取类型
收费全文 | 124636篇 |
免费 | 44316篇 |
国内免费 | 646篇 |
专业分类
耳鼻咽喉 | 1880篇 |
儿科学 | 5288篇 |
妇产科学 | 718篇 |
基础医学 | 26567篇 |
口腔科学 | 7004篇 |
临床医学 | 14973篇 |
内科学 | 28295篇 |
皮肤病学 | 4730篇 |
神经病学 | 18531篇 |
特种医学 | 6110篇 |
外国民族医学 | 1篇 |
外科学 | 15923篇 |
综合类 | 2622篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 8714篇 |
眼科学 | 1451篇 |
药学 | 10624篇 |
5篇 | |
中国医学 | 2156篇 |
肿瘤学 | 13997篇 |
出版年
2024年 | 16篇 |
2023年 | 188篇 |
2022年 | 367篇 |
2021年 | 2010篇 |
2020年 | 6401篇 |
2019年 | 11819篇 |
2018年 | 11325篇 |
2017年 | 12556篇 |
2016年 | 11609篇 |
2015年 | 11532篇 |
2014年 | 11613篇 |
2013年 | 11794篇 |
2012年 | 10910篇 |
2011年 | 11004篇 |
2010年 | 9551篇 |
2009年 | 6044篇 |
2008年 | 6643篇 |
2007年 | 5083篇 |
2006年 | 4831篇 |
2005年 | 4531篇 |
2004年 | 4398篇 |
2003年 | 4118篇 |
2002年 | 3858篇 |
2001年 | 3027篇 |
2000年 | 1856篇 |
1999年 | 697篇 |
1998年 | 342篇 |
1997年 | 278篇 |
1996年 | 181篇 |
1995年 | 136篇 |
1994年 | 118篇 |
1993年 | 89篇 |
1992年 | 83篇 |
1991年 | 66篇 |
1990年 | 57篇 |
1989年 | 52篇 |
1988年 | 38篇 |
1987年 | 28篇 |
1986年 | 23篇 |
1985年 | 74篇 |
1984年 | 47篇 |
1983年 | 21篇 |
1982年 | 39篇 |
1981年 | 29篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1978年 | 16篇 |
1976年 | 12篇 |
1975年 | 13篇 |
1974年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 671 毫秒
1.
2.
3.
4.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
5.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
6.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献
7.
8.
9.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献
10.